Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Erlotinib in Solid Tumors and NSCLC
NCT00390429Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Jul 2002
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in solid tumor, non-small cell lung cancer (NSCLC), sponsored by University of California, Davis. Started Jul 2002; status: completed.
02
Drugs
erlotinib
03
Conditions
solid tumornon-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00390429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390429.